Scoop +
Login
Trending
OTT
Webstory
Extra Lens
Cutshort
Podcasts
Youth
Election
Search News
Search
Login
Scoop
News
SII to launch Covovax covid jab for children aged 3 plus soon; Click to know deets
COVAXIN receives a yes to conduct Phase 2/3 clinical trials on children: NITI Aayog
Covaxin receives green flag for Phase 2/3 clinical trials on 2-18 age group
Why Rs 35,000cr budgeted for vaccination? States ask centre govt over different vaccine pricing
Serum Institute expresses optimism on the payment of Rs 3,000 crore
Covishield Covid-19 vaccine cost Rs 200 a flask, purchase order likely today, sources
Serum Institute, Bharat Biotech to work jointly for ‘smooth rollout’ of covid-19 vaccines in India & globally
Oxford-Astrazeneca vaccine will commercially cost ₹ 1,000 per dose if govt allows us to sell: Adar Poonawalla